You are viewing archived content

Please note that this page is a static copy of a previously published web page and is no longer actively maintained.
Be aware that the information contained here may be out-of-date.
For the most recent information, we recommend visiting the main website of the EMCDDA.

Table TDI-10. Distribution of clients entering treatment according to age and primary drug - EU overall summary in 2005 [see all tables in this series...]

Part (iv) Distribution of all outpatient clients by primary drug for each age group

Substance	<15	15-19	20-24	25-29	30-34	35-39	40-44	45+	Age known	Age not known
Opioids	4.8	16.7	43.6	57.3	64.0	67.4	68.0	59.2	167149	388
Cocaine	1.9	9.0	15.2	18.6	19.3	17.6	17.3	14.5	51098	114
Stimulants	4.0	7.8	6.4	4.2	3.0	2.6	2.1	3.3	13553	23
Hypnotics and sedatives	0.6	0.9	1.1	1.3	1.8	2.3	3.0	9.0	6454	181
Hallucinogens	0.2	0.4	0.3	0.2	0.1	0.1	0.1	0.1	644	2
Volatile substances	5.7	0.8	0.3	0.1	0.1	0.1	0.1	0.1	843	2
Cannabis	81.1	63.2	31.4	16.7	10.0	8.1	7.5	9.5	67184	217
Other substances	1.7	1.2	1.7	1.5	1.7	1.8	1.9	4.4	5658	132
Total	3009	32841	63084	65847	56777	44162	27122	19741	312583	1059

Notes:

The countries supplying data are:

BG, CZ, DK, DE, IE, EL, ES, FR, IT, CY, LT, LU, HU, MT, NL, SK, FI, SE, UK

Last data available from Spain refer to year of treatment 2004.

The number of treatment clients in each country is listed in [Table TDI-7].

See also 'TDI-103-All outpatient age and primary drug.xls' on distribution by country and 'General notes for interpreting data' on the Explanatory notes and help page.

Sources:

2006 Reitox national reports - Table TDI outpatient treatment centres.